Related content

Development of new predictive markers for endocrine therapy and resistance in breast cancer

By Henriksen Katrine   Sonne-Hansen Katrine   Kirkegaard Tove   Frogne Thomas   Lykkesfeldt Anne  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 795-801

Informa Healthcare

Access to resources Recommend Favorite

Analysis of factors affecting endocrine therapy resistance in breast cancer

By      

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 379-384

Spandidos Publications

Access to resources Recommend Favorite

ERβ overexpression results in endocrine therapy resistance and poor prognosis in postmenopausal ERα-positive breast cancer patients

By          

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 1531-1536

Spandidos Publications

Access to resources Recommend Favorite

Neoadjuvant endocrine therapy of breast cancer: a surgical perspective

By Dixon J.M.   Anderson T.J.   Miller W.R.  

European Journal of Cancer, Vol. 38, Iss. 17, 2002-11 ,pp. : 2214-2221

Elsevier

Access to resources Recommend Favorite

Guidelines on endocrine therapy of breast cancerEUSOMA

By Blamey R.W.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 615-634

Elsevier

Access to resources Recommend Favorite